Cinqair: Severe Asthma Treatment

Cinqair is a prescription medication used as an add-on treatment for severe asthma. It works by reducing levels of a certain type of white blood cell that may contribute to asthma symptoms.
Category
Drug
Where to get
Available by prescription only in hospitals and specialized pharmacies.
Applicable for
Reslizumab
reduction of eosinophils
Prepared by Lee Cheng, reviewed by Dr. Helena Rodriguez

Cinqair FAQ


Image credit: laboratoriochile.cl

What is Cinqair used for?

Cinqair is a prescription medicin eused together with other medicines to help control severe asthma. Cinqair is used in people aged 18 years of age and older whose asthma is not controlled by their current asthma medicines. Some people have had allergic reactions to Cinqair during or shortly after the injection.

How much does Cinqair cost?

CINQAIR is an add-on prescription medication for people 18 years of age and older whose asthma is not controlled by their current medication. The only anti-IL-5 with personalized weight-based dosing. (up to $10,000 per year).*

Who is Cinqair approved for?

Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines. Asthma is a chronic disease that causes inflammation in the airways of the lungs. During an asthma attack, airways become narrow making it hard to breathe.

Does Cinqair reduce severe asthma attacks?

Cinqair reduces severe asthma attacks by reducing the levels of blood eosinophils, a type of white blood cell that contributes to the development of asthma. The safety and efficacy of Cinqair were established in four double-blind, randomized, placebo‑controlled trials in patients with severe asthma on currently available therapies.

What is Cinqair?

CINQAIR is a prescription medicine used with other asthma med- icines for the maintenance treatment of asthma in people aged 18 years of age and older whose asthma is not controlled with the current asthma medicines.

What is the mechanism of action of Cinqair in asthma?

The mechanism of CINQAIR action in asthma has not been definitively established. 1 Severe asthma that is inadequately controlled despite standard of care (medium-high dose ICSs with LABAs) 1-3 At least 1 asthma exacerbation requiring use of OCSs over the past 12 months 1,4

Does Cinqair help eosinophilic asthma?

CINQAIR was studied in people with poorly controlled, severe asthma and a higher than normal level of eosinophils. When added to their other asthma treatments, CINQAIR provided relief as early as 4 weeks. Plus, improvements were seen through the end of the 1-year studies. severe eosinophilic asthma symptoms and attacks.

Cinqair References

If you want to know more about Cinqair, consider exploring links below:

Explore Related Topics

The Role of Monoclonal Antibodies in Pediatric Asthma Treatment

Discussing the use of monoclonal antibodies in treating severe asthma among children, share your concerns, experiences, or questions.

Monoclonal Antibodies and Asthma: Debunking Myths

There are many myths surrounding the use of monoclonal antibodies in asthma treatment. Let's debunk these myths and spread factual information.

How to Advocate for Access to Monoclonal Antibody Treatments

Gaining access to monoclonal antibody treatments can be a challenge for many. Share tips and experiences on advocating for yourself or loved ones.

How Immunotherapy for Asthma Fits into Long-term Management Plans

Discuss how immunotherapy integrates with other asthma management plans for long-term control and quality of life improvements. Share tips and strategies.

Breaking Down Steroid Resistance in Asthma: Myth or Reality?

Explore the concept of steroid resistance in asthma. Is it a significant concern or a rare occurrence? Share your insights or questions.

Understanding the Different Types of Monoclonal Antibodies for Asthma

With various monoclonal antibodies available for asthma, navigating the options can be complex. Join the discussion to understand the differences.

Navigating Insurance and Access to Biologic Therapies for Asthma

Discuss the challenges and solutions related to insurance coverage and access to biologic treatments for asthma.

Understanding the Risks vs. Benefits of Immunotherapy for Asthma

Weigh the risks against the benefits of undergoing immunotherapy for asthma. Share resources, expert opinions, and personal viewpoints to help others make informed decisions.

Who Qualifies for Monoclonal Antibody Treatments for Asthma?

Navigating the criteria for monoclonal antibody treatments can be confusing. Let's break down who benefits most from this advanced therapy.

Biologics: The Future of Personalized Asthma Therapy?

Investigating the impact of biologic medications on personalized asthma therapy and if they are shaping the future of asthma care.

Can Monoclonal Antibodies Improve Quality of Life for Severe Asthma Patients?

If you or someone you know has experienced the impact of monoclonal antibodies on severe asthma, share your stories here. Let's discuss the quality of life improvements.

Biologic Therapies for Asthma: Hope or Hype?

Delve into the world of biologic therapies for severe asthma, understanding their mechanism, benefits, and potential limitations.

Is Immunotherapy a Game Changer for Asthma Sufferers?

This thread aims to explore the impact of immunotherapy on asthma management and its potential to change the lives of those affected. Discuss your experiences and thoughts about this emerging treatment.